Fri, Jul 25, 2014, 5:03 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

InVivo Therapeutics Holdings Corp. Message Board

  • analystnueve analystnueve Jan 18, 2013 12:31 AM Flag

    Great Info For New Investors

    The latest Crystal Reports dated December 13th, 2012 for NVIV is an outstanding document that is quite informative. It will answer a whole host of questions and even clarifies certain points that all longer termed investors may not fully be aware of. Excellent and definitely reassuring. If you can handle the ups and downs and the frustrating delays, I believe all will be well served investing here.

    Great probability that by March or sooner (as with the HUD) that FDA will have granted both the HUD and the IDE approvals and human trials ready to roll.

    Geisinger peripheral study should be done and reported. This would boost the prospects of the first hydrogel product in terms of demonstrating safety and efficacy as well as speeding up its time to market.

    Getting in or expanding shares now under $3 is a great buy, as these days are numbered.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NVIV
0.95-0.01(-1.04%)Jul 25 3:53 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.